Key facts
- This page summarizes BOSTON SCIENTIFIC CORP's Form 4 filing for Pulmonx Corp (LUNG).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 14 Jul 2021, 16:10.
BOSTON SCIENTIFIC CORP - 13 Jul 2021 Form 4 Insider Report for Pulmonx Corp (LUNG)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- LUNG
- Reported as of
- 13 Jul 2021
- Net transaction value
- -$93,625,000
- Reporting owner signature
- /s/Vance R. Brown, SVP, General Counsel and Corporate Secretary
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
BOSTON SCIENTIFIC CORP filed Form 4 for Pulmonx Corp (LUNG) on 14 Jul 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: -$93,625,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LUNG
transaction
Common Stock
Sale
- Transaction value
- $93,625,000
- Shares
- -2,500,000
- Change %
- -63%
- Price
- $37.45
- Shares after
- 1,488,106
- Date
- 13 Jul 2021
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
These shares of the Issuer's common stock were sold in a block order at a price of $37.45.